摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-已氧基苯甲酰氯 | 39649-71-3

中文名称
4-已氧基苯甲酰氯
中文别名
4-正己氧基苯甲酰氯
英文名称
4-hexyloxybenzoyl chloride
英文别名
4-n-hexyloxybenzoic acid chloride;4-hexoxybenzoyl chloride
4-已氧基苯甲酰氯化学式
CAS
39649-71-3
化学式
C13H17ClO2
mdl
MFCD00000690
分子量
240.73
InChiKey
DQQOONVCLQZWOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    213-214 °C30 mm Hg(lit.)
  • 密度:
    1.081 g/mL at 25 °C(lit.)
  • 闪点:
    >230 °F
  • 稳定性/保质期:

    常规情况下不会分解,也没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.461
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • TSCA:
    Yes
  • 危险等级:
    8
  • 危险品标志:
    C
  • 安全说明:
    S26,S27,S28,S36/37/39,S45
  • 危险类别码:
    R34
  • WGK Germany:
    3
  • 海关编码:
    2918990090
  • 危险品运输编号:
    UN 3265 8/PG 2
  • 包装等级:
    II
  • 危险类别:
    8
  • 储存条件:
    密封、阴凉、干燥保存

SDS

SDS:c42a93705995a4c6f29c65d3420debb5
查看
Name: 4-Hexyloxybenzoyl Chloride 98% Material Safety Data Sheet
Synonym: None Known
CAS: 39649-71-3
Section 1 - Chemical Product MSDS Name:4-Hexyloxybenzoyl Chloride 98% Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
39649-71-3 4-Hexyloxybenzoyl Chloride 98% 254-561-3
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye irritation and possible burns. May cause chemical conjunctivitis.
Skin:
Causes skin irritation and possible burns.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause cardiac disturbances. May cause central nervous system effects.
Inhalation:
May cause cardiac abnormalities. Can produce delayed pulmonary edema. Causes respiratory tract irritation with possible burns.
Central nervous system effects, which appear to predominate in acute cases are characterized by abnormal fatigue, memory difficulties and dizziness.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode in the heat of a fire. Vapors may be heavier than air.
They can spread along the ground and collect in low or confined areas. Contact with metals may evolve flammable hydrogen gas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Do NOT get water inside containers. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use dry chemical, carbon dioxide, alcohol-resistant foam, or water spray.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation. Do not get water inside containers.

Section 7 - HANDLING and STORAGE
Handling:
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Do not allow contact with water. Wash clothing before reuse. Keep from contact with moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from moisture.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 39649-71-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 213-214 deg C (30mm)
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H17ClO2
Molecular Weight: 240.5708

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, moisture, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Moisture, alcohols, oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 39649-71-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Hexyloxybenzoyl Chloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, N.O.S.*
Hazard Class: 8
UN Number: 1760
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing group: II

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 39649-71-3: No information available.
Canada
CAS# 39649-71-3 is listed on Canada's NDSL List.
CAS# 39649-71-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 39649-71-3 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and Mesomorphic Properties of the Homologous Series of 4-Alkyl or Alkoxy-4′-Bromo or Cyanotolanes
    摘要:
    DOI:
    10.1080/15421408008084015
  • 作为产物:
    描述:
    1-氯己烷氢氧化钾氯化亚砜N,N-二甲基甲酰胺 、 potassium iodide 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 11.0h, 生成 4-已氧基苯甲酰氯
    参考文献:
    名称:
    Synthesis of Novel Discotic Mesogen Containing Electron-Transportable Oxadiazole Moiety
    摘要:
    We synthesized and characterized a novel discotic liquid crystalline material (MOD) composed of 1,3,5-tri-substituted benzene core and 2-(4-hexyloxyphenyl)-oxadiazol-5-yl arms. Chemical structure of THOB was characterized using H-1-NMR and mass spectroscopy and its thermal behavior was determined. using DSC and polarized optical microscopy. THOB showed narrow mesophase region at around 128 degreesC and exhibited nernatic-like texture.
    DOI:
    10.1080/10587250108030113
点击查看最新优质反应信息

文献信息

  • Synthesis, characterization, and mesomorphic investigations of diester-substituted salicylaldimines and their copper (II) complexes
    作者:Sachin Kumar Singh、Madan Kumar Singh、Hemant Kumar Singh、Bachcha Singh
    DOI:10.1080/15421406.2015.1044196
    日期:2016.1.2
    ABSTRACT A novel homologous series of N-[4-[4′-n-alkoxy)benzoyloxy-2-hydroxybenzylidene)-4-carbethoxy anilines, H2n+1CnOC6H4C(O)OC6H3(OH)C(H)˭NC6H4COOC2H5 (n = 6, 8, 10, 12, 14, 16) and their copper(II) complexes have been synthesized. All these compounds have been characterized by suitable spectroscopic techniques. The mesomorphic properties of these compounds were investigated by differential scanning calorimetry
    摘要 N-[4-[4'-n-烷氧基)苯甲酰氧基-2-羟基亚苄基)-4-甲氧基苯胺,H2n+1CnOC6H4C(O)OC6H3(OH)C(H)˭NC6H4COOC2H5 (n = 6, 8, 10, 12, 14, 16) 及其 (II) 络合物已被合成。所有这些化合物均已通过合适的光谱技术表征。通过差示扫描量热法 (DSC) 和偏光显微镜 (POM) 研究了这些化合物的介晶性质。这些配体表现出广泛的对映性近晶 A 和向列相,这由它们在偏光显微镜下的典型光学结构所证实。配体的方形平面 (II) 配合物在较高温度下仅显示各向同性相,未观察到介晶性质。
  • Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides
    申请人:ELI LILLY AND COMPANY
    公开号:EP0825164A2
    公开(公告)日:1998-02-25
    This invention relates to a novel solution phase process for the preparation of amide, carbamate, and sulfonamide combinatorial libraries. These libraries have utility for drug discovery and are used to form wellplate components of novel assay kits.
    这项发明涉及一种用于制备酰胺、碳酸酯和磺酰胺组合库的新型溶液相过程。这些库在药物发现中具有实用价值,并用于形成新型检测套件的微孔板组件。
  • Synthesis, Structures, and Aggregation Properties of N-Acylamidines
    作者:Christof Wigbers、Jörg Prigge、Zhongchen Mu、Roland Fröhlich、Lifeng Chi、Ernst-Ulrich Würthwein
    DOI:10.1002/ejoc.201001155
    日期:2011.2
    pattern. Thus, dimeric (1c, 1d, and 1u) and tetrameric (1f) aggregates with strong NH···OC hydrogen bonding, as well as polymeric chain structures (1x and 1z) were observed in the solid state. Furthermore, a dimer 1k involving only the amidine subunits, rather than the carbonyl function, was found. Monolayers of molecules 1u and 1ab physisorbed at the liquid/HOPG (high orientated pyrolytic graphite)
    N-酰基脒1a-q 是属离子络合的重要配体,可以通过脒2 的酰化或用胺处理N-酰基酰亚胺3 来轻松制备。此外,脒盐与芳酰卤氢氧化钠存在下的反应得到芳基衍生物 1r-1ad 和三种偶氮苯生物 1ae-1ag。这些新型衍生物的各自取代模式是根据配位反应中可能的空间和电子效应以及聚集特性来选择的。N-酰基脒 1 可能以三种类型的互变异构体形式存在,通过 NMR 光谱分析和量子化学 DFT 和 SCS-MP2 计算对气相中的单分子在溶液中进行检查。内部旋转需要 3–17 (C–N) 和 15–27 (C=N) kcal/mol 之间的活化能。由于它们形成分子内和分子间氢键的出色能力,这些分子在固态(X 射线分析)和表面上显示出非常多变的聚集行为,这取决于取代模式。因此,在固态下观察到具有强NH···OC氢键的二聚体(1c、1d和1u)和四聚体(1f)聚集体以及聚合物链结构(1x和1z)。此外
  • Benzoic acid derivatives and related compounds as antiarrhythmic agents
    申请人:——
    公开号:US20020137968A1
    公开(公告)日:2002-09-26
    Benzoic acid derivatives of the formula I 1 where X is oxygen, sulfur, —NH, —NR 1 , —N—CN, —N—OR 1 or —N—NO 2 ; Y is a single bond, —C═C—, or —NH; R 1 is alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocyclo, or (heterocyclo)alkyl; and R 2 is aryl or heterocyclo. The compounds of formula I are useful in the treatment of arrhythmia.
    公式I的苯甲酸生物 其中X为氧、、—NH、—NR 1 、—N—CN、—N—OR 1 或—N—NO 2 ; Y为单键、—C═C—或—NH; R 1 为烷基、烯基、炔基、芳基、环烷基、杂环烷基或(杂环烷基);和 R 2 为芳基或杂环烷基。公式I的化合物在心律失常的治疗中很有用。
  • PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
    申请人:MORITA Kohei
    公开号:US20100093819A1
    公开(公告)日:2010-04-15
    A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA 2 , and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].
    由以下一般式(1)表示的化合物或其盐,具有优越的抑制对4型PLA2的活性,因此具有前列腺素和/或白三烯产生抑制作用【X代表卤素原子、可能被取代的烷基或类似物,Y代表氢原子或可能被取代的烷基,Z代表氢原子或可能被取代的烷基】。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫